These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 13156131)

  • 1. [Experience with discontinuous heparin in coronary insufficiency].
    SAN-CRISTOBAL D; SEPULVEDA G
    Rev Med Chil; 1953 Nov; 81(11):662-5. PubMed ID: 13156131
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of heparin in the treatment of coronary diseases; heparin in coronary diseases except infarct].
    CAMERON-CURRY V
    Minerva Med; 1957 Jan; 48(6):183-7. PubMed ID: 13418464
    [No Abstract]   [Full Text] [Related]  

  • 3. [Subcutaneous heparin treatment in cardiosclerosis].
    VON AHN B
    Sven Lakartidn; 1957 Dec; 54(52):3945-55. PubMed ID: 13519397
    [No Abstract]   [Full Text] [Related]  

  • 4. A randomized comparative study of using enoxaparin instead of unfractionated heparin in the intervention treatment of coronary heart disease.
    Chen JL; Chen J; Qiao SB; Guo YL; Wu YJ; Dai J; Yuan JQ; Qin XW; Yang YJ; Gao RL
    Chin Med J (Engl); 2006 Mar; 119(5):355-9. PubMed ID: 16542576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of heparin in arteriosclerotic coronary diseases].
    SCHIROSA G; GUARINI G
    Atti Soc Ital Cardiol; 1956; 1():119-21. PubMed ID: 13328642
    [No Abstract]   [Full Text] [Related]  

  • 6. Heparin-bonded cardiopulmonary bypass circuits reduce the rate of red blood cell transfusion during elective coronary artery bypass surgery.
    Kreisler KR; Vance RA; Cruzzavala J; Mahnken JD
    J Cardiothorac Vasc Anesth; 2005 Oct; 19(5):608-11. PubMed ID: 16202894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial.
    White HD; Kleiman NS; Mahaffey KW; Lokhnygina Y; Pieper KS; Chiswell K; Cohen M; Harrington RA; Chew DP; Petersen JL; Berdan LG; Aylward PE; Nessel CC; Ferguson JJ; Califf RM
    Am Heart J; 2006 Dec; 152(6):1042-50. PubMed ID: 17161049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel technique for coronary bifurcation lesions: cutting balloons, drug-eluting stents and the kissing technique.
    Wong CB; Hardin S
    J Invasive Cardiol; 2005 Feb; 17(2):108-10. PubMed ID: 15687538
    [No Abstract]   [Full Text] [Related]  

  • 9. Heparin clearing and inhibition in ischaemic heart disease.
    NESTEL PJ; MASHFORD ML
    Clin Sci; 1961 Feb; 20():41-8. PubMed ID: 13728415
    [No Abstract]   [Full Text] [Related]  

  • 10. Low-molecular-weight heparin vs. unfractionated heparin in percutaneous coronary intervention: a combined analysis.
    Borentain M; Montalescot G; Bouzamondo A; Choussat R; Hulot JS; Lechat P
    Catheter Cardiovasc Interv; 2005 Jun; 65(2):212-21. PubMed ID: 15900551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct thrombin inhibitors (part 1 of 2).
    Arora UK; Dhir M
    J Invasive Cardiol; 2005 Jan; 17(1):34-8. PubMed ID: 15640538
    [No Abstract]   [Full Text] [Related]  

  • 12. [The use of heparin as a clearing agent in acute and chronic coronary insufficiency].
    CARUZZO C; PELLEGRINI A; PAGANO PG; TARTARA D; ANGELINO PF
    Atti Soc Ital Cardiol; 1962; 22(2)():Comunicazioni 79-80. PubMed ID: 14018997
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experience with the use of heparin in ambular prevention of coronary thrombosis under ambulatory conditions].
    Aleĭnikova LI
    Kardiologiia; 1965; 5(4):50-2. PubMed ID: 5880731
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of low-molecular-weight heparin in invasive management of non-ST-elevation acute coronary syndromes.
    Moser LR; Kalus JS
    Ann Pharmacother; 2004 Dec; 38(12):2094-104. PubMed ID: 15536140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE).
    Brieger D; Van de Werf F; Avezum A; Montalescot G; Kennelly BM; Granger CB; Goodman SG; Dabbous OH; Agnelli G;
    Am Heart J; 2007 Jun; 153(6):960-9. PubMed ID: 17540196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct thrombin inhibitors in acute coronary syndromes: effect in patients undergoing early percutaneous coronary intervention.
    Sinnaeve PR; Simes J; Yusuf S; Garg J; Mehta S; Eikelboom J; Bittl JA; Serruys P; Topol EJ; Granger CB
    Eur Heart J; 2005 Nov; 26(22):2396-403. PubMed ID: 16214829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Six hour ambulation after elective coronary angioplasty and stenting with 7F guiding catheters ald low dose heparin.
    Tengiz I; Ercan E; Bozdemir H; Durmaz O; Gurgun C; Nalbantgil I
    Kardiol Pol; 2003 Feb; 58(2):93-7. PubMed ID: 14504634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-molecular-weight heparin during percutaneous coronary interventions: rationale, results, and recommendations.
    Levine GN; Ferguson JJ
    Catheter Cardiovasc Interv; 2003 Oct; 60(2):185-93. PubMed ID: 14517923
    [No Abstract]   [Full Text] [Related]  

  • 19. Incidence of antiplatelet factor 4/heparin antibody induction in patients undergoing percutaneous coronary revascularization.
    Gluckman TJ; Segal JB; Fredde NL; Saland KE; Jani JT; Walenga JM; Prechel MM; Citro KM; Zidar DA; Fox E; Schulman SP; Kickler TS; Rade JJ
    Am J Cardiol; 2005 Mar; 95(6):744-7. PubMed ID: 15757601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of heparin-PF4 complex antibody formation and heparin-induced thrombocytopenia in acute coronary syndrome.
    Matsuo T; Tomaru T; Kario K; Hirokawa T;
    Thromb Res; 2005; 115(6):475-81. PubMed ID: 15792678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.